Join NHLBI's Free Chat on Heart and Lung Research Policies
Published Date: 4/23/2026
Notice
Summary
The National Heart, Lung, and Blood Institute is holding a public meeting on June 9, 2026, to talk about important program policies. Anyone interested can attend in person or watch online, and people can even request to speak or send comments ahead of time. This is a great chance for the public and organizations to get involved with health research decisions—no registration needed and no cost to join!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Free public access — in person or online
You can attend the National Heart, Lung, and Blood Advisory Council meeting on June 9, 2026 (8:30 a.m. to 12:00 p.m.) in person at the NIH Claude D. Pepper Building in Bethesda, MD, or watch the open session videocast online. Registration is not required and there is no cost to join.
How to speak or submit comments
If you want to present oral comments at the meeting, you must notify the Contact Person at least 10 days before June 9, 2026. Organizations may send one representative, presentations may be limited to five minutes, and both printed and electronic copies are requested; written comments may also be filed with the Contact Person and should include name, address, phone number, and affiliation when applicable.
Accommodations and security entry rules
If you need special assistance (for example, sign language interpretation) you should notify the Contact Person in advance of the June 9, 2026 meeting. For security, visitors must show one form of photo ID (for example, a driver's license or passport) and all visitor vehicles will be inspected before being allowed on campus.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08456 — Proposed Collection; 60-Day Comment Request; NIH Office of Intramural Training & Education-Application, Registration, and Alumni Systems Office of the Director
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
Previous / Next Documents
Previous: 2026-07910 — Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments
The FDA is updating the list of harmful chemicals found in tobacco products and smoke, making it clearer which substances are dangerous. This affects tobacco companies, health experts, and the public by pushing for better awareness and safety. Comments on these changes are open until May 26, 2026, so speak up if you have thoughts!
Next: 2026-07912 — National Heart, Lung, and Blood Institute; Notice of Closed Meeting
The National Heart, Lung, and Blood Institute is holding a closed meeting on June 9, 2026, to review and decide on grant applications. This meeting affects researchers seeking funding and keeps sensitive info private. No public attendance is allowed, but written comments can be sent in advance.